William Olson, PhD has 30 years of experience in the discovery and development of antibodies and other biologics. His efforts have resulted in the generation of dozens of novel agents that advanced into clinical testing. As Vice President, Therapeutic Proteins, he currently leads a team dedicated to supplying the Regeneron pipeline with novel, fully human antibody-based therapies generated using the VelocImmuneTM mouse platform. At Regeneron, Dr. Olson also spearheads initiatives on structural biology, chemistry and antibody-based imaging. His prior industry experience includes leadership positions at Progenics Pharmaceuticals and Johnson & Johnson. He received a Bachelor’s of Science degree from the University of North Dakota and a PhD in Biochemical Engineering from the Massachusetts Institute of Technology.